Super-Fine ultrasound could spare melanoma patients a second surgery
NCT ID NCT04702854
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial investigates whether a new, ultra-high-frequency ultrasound device can accurately measure the depth of skin melanomas before surgery. Currently, doctors must remove the tumor, measure its depth under a microscope, and then often perform a second surgery to remove more tissue or check lymph nodes. If this ultrasound method proves reliable, it could allow doctors to plan and perform the complete treatment in one operation. The study will enroll 60 adults with suspected melanoma and compare the ultrasound measurements to the standard lab analysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ultrasound Biomicroscopy (VEVO MD device)
- What this could lead to
- If successful, this imaging method could allow doctors to determine melanoma depth before the first surgery, enabling complete removal and lymph node analysis in a single procedure.
- What could go wrong
- This is a small, early-stage study with only 60 participants. Previous high-frequency ultrasound attempts were not accurate enough, and this new approach may also fail to match the gold-standard histological measurement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- E-Learning could sharpen Doctors' eye for skin cancer
- Can a new drug tame advanced solid tumors?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- Could starting immunotherapy earlier improve outcomes for High-Risk melanoma?